Follow-on offering Announced Sponsor exit
Medline equity raising
US$3.1bn raised
Announced 4 Mar 2026 · NASDAQ: MDLN
Advisers
Lead managers
- Bookrunner
- Barclays
(co)Citi
(co)Deutsche Bank
(co)Jefferies
(co)UBS (co)Evercore
(co)BMO Capital Markets (co)BNP Paribas (co)MUFG (co)RBC Capital Markets (co)Santander (co)TD Securities (co)Nomura
(co)WR Securities (co)Leerink Partners (co)Macquarie Capital
(co)Mizuho Securities (co)Piper Sandler (co)Truist Securities (co)William Blair
(co) - Underwriter
- Goldman Sachs
(co)Morgan Stanley
(co)BofA Securities
(co)J.P. Morgan
(co) - Co-manager
- TCG Capital Markets (co)Rothschild & Co (co)Stifel
(co)BTIG (co)ING (co)NCMG (co)Academy Securities (co)AmeriVet Securities (co)Blaylock Van (co)Drexel Hamilton (co)Loop Capital Markets (co)R. Seelaus & Co. (co) - Legal adviser
- Issuer
- Medline
- Seller
- Blackstone
- Issuer based in
- United States
- Sector
- Healthcare
- Tags
- Healthcare, Distribution, Medtech
Similar deals
- Medline equity raising May 2026 · US$2.7bn · Healthcare
- MiniMed Group IPO Mar 2026 · US$560m · Medtech
- Anteris Technologies Global Corp. placement Oct 2025 · US$320m · Medtech
- EBOS Group placement Apr 2025 · US$163m · Healthcare
- Saluda Medical IPO Dec 2025 · US$154m · Medtech
Sources
- 6 Mar 2026 Final IPO prospectus (424B4), Medline Inc. sec.gov


